| Business Summary | | Kendle
International
Inc.
is
a
contract
research
organization
that
provides
a
broad
range
of
Phase
I
through
IV
clinical
research
and
drug
development
services
to
the
pharmaceutical
and
biotechnology
industries.
The
Company
augments
the
research
and
development
activities
of
pharmaceutical
and
biotechnology
companies
by
offering
value-added
clinical
research
services
and
proprietary
information
technology
designed
to
reduce
drug
development
time
and
expense.
The
Company
is
organized
into
two
segments
for
financial
reporting
purposes.
The
contract
research
services
group
conducts
clinical
trial
management,
clinical
data
management,
statistical
analysis,
medical
writing
and
regulatory
consulting
and
representation.
The
medical
communications
group,
Health
Care
Communications
Inc.,
a
wholly
owned
subsidiary
of
the
Company,
provides
organizational,
meeting
management
and
publication
services
to
professional
associations
and
pharmaceutical
companies. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Kendle
International
Inc.
is
a
contract
research
organization
providing
integrated
clinical
research
services
on
a
contract
basis
to
the
pharmaceutical
and
biotechnology
industries.
For
the
six
months
ended
6/30/01,
revenues
increased
10%
to
$70.9
million.
Net
income
totalled
$1.1
million
vs.
a
loss
of
$920
thousand.
Revenues
reflect
growth
from
acquisitions.
Earnings
reflect
the
absence
of
employee
severance
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Candace Kendle, 54 CEO,
Chairman | $246K | Christopher Bergen, 50 Pres,
COO, Director | 229K | Timothy Mooney, 53 Exec.
VP, CFO, Treasurer, Director | 188K | Thomas Stilgenbauer, 53 Exec.
VP and Chief Marketing Offficer | 185K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|